BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 37759525)

  • 21. Detection of epigenetic aberrations in the development of hepatocellular carcinoma.
    Zhang Y
    Methods Mol Biol; 2015; 1238():709-31. PubMed ID: 25421688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TMT-HCC: a tool for text mining the biomedical literature for hepatocellular carcinoma (HCC) biomarkers identification.
    Abul Seoud RA; Mabrouk MS
    Comput Methods Programs Biomed; 2013 Dec; 112(3):640-8. PubMed ID: 23978553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes.
    Ito Y
    Adv Cancer Res; 2008; 99():33-76. PubMed ID: 18037406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
    Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
    Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular targets for prevention of hepatocellular carcinoma.
    Blum HE
    Dig Dis; 2002; 20(1):81-90. PubMed ID: 12145424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular diagnosis of multistage hepatocarcinogenesis.
    Sakamoto M; Effendi K; Masugi Y
    Jpn J Clin Oncol; 2010 Sep; 40(9):891-6. PubMed ID: 20603246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.
    Spender LC; Whiteman HJ; Karstegl CE; Farrell PJ
    Oncogene; 2005 Mar; 24(11):1873-81. PubMed ID: 15688019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.
    Rizzo F; Rinaldi A; Marchese G; Coviello E; Sellitto A; Cordella A; Giurato G; Nassa G; Ravo M; Tarallo R; Milanesi L; Destro A; Torzilli G; Roncalli M; Di Tommaso L; Weisz A
    Oncotarget; 2016 Aug; 7(34):54650-54661. PubMed ID: 27429044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
    Niu ZS; Niu XJ; Wang WH
    World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.
    Zhou Y; Liu F; Ma C; Cheng Q
    J Clin Lab Anal; 2022 Oct; 36(10):e24673. PubMed ID: 36036748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications.
    Sun J; Lu H; Wang X; Jin H
    ScientificWorldJournal; 2013; 2013():924206. PubMed ID: 23431261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma.
    Lau SH; Guan XY
    Acta Pharmacol Sin; 2005 Jun; 26(6):659-65. PubMed ID: 15916730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.
    Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D
    World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma.
    Kanda M; Sugimoto H; Kodera Y
    World J Gastroenterol; 2015 Oct; 21(37):10584-97. PubMed ID: 26457018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular therapy and prevention of hepatocellular carcinoma.
    Blum HE
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):11-22. PubMed ID: 14599923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics.
    Khan FS; Ali I; Afridi UK; Ishtiaq M; Mehmood R
    Hepatol Int; 2017 Jan; 11(1):45-53. PubMed ID: 27271356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Runx genes: lineage-specific oncogenes and tumor suppressors.
    Cameron ER; Neil JC
    Oncogene; 2004 May; 23(24):4308-14. PubMed ID: 15156187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.
    Yuan BZ; Zhou X; Zimonjic DB; Durkin ME; Popescu NC
    J Mol Diagn; 2003 Feb; 5(1):48-53. PubMed ID: 12552080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis.
    El Khodiry A; Afify M; El Tayebi HM
    World J Gastroenterol; 2018 Feb; 24(5):549-572. PubMed ID: 29434445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.